Logotype for Grupo Nutresa S A

Grupo Nutresa (NUTRESA) Q2 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Grupo Nutresa S A

Q2 2025 earnings summary

4 Sep, 2026

Executive summary

  • Achieved double-digit consolidated growth in sales and EBITDA for the first half of 2025, demonstrating resilience amid volatile commodity prices and ongoing transformation initiatives focused on cost optimization, digital acceleration, and operational efficiencies.

  • Revenues for H1 2025 reached COP 10.04 trillion, up 14.5% year-over-year, with dynamic growth in both Colombia and international markets.

  • EBITDA for H1 2025 was COP 1.48 trillion, up 24.4%, with a margin of 14.7%; adjusted EBITDA margin was 15.3%.

  • Net profit attributable to controlling interest for H1 2025 was COP 712.8 billion, nearly doubling year-over-year, driven by operational improvements and minority share sales.

  • Share buyback program executed, with up to 1.1 million shares repurchased.

Financial highlights

  • Q2 2025 sales reached COP 5.2 trillion, up 15.8% year-over-year; H1 sales totaled COP 10.04 trillion, up 14.5%.

  • EBITDA for Q2 2025 (excluding non-recurring expenses) was COP 791 billion (15.3% margin), up 32.4% year-over-year.

  • Net profit for Q2 2025 was COP 475.3 billion, up 142.2% year-over-year; H1 net profit was COP 712.8 billion, up 94.8%.

  • Operating profit for H1 2025 was COP 1.25 trillion, up 35.8% year-over-year.

  • Net cash flow from operating activities for H1 2025 was COP 974.6 billion, up from COP 565.5 billion in 2024.

Outlook and guidance

  • Focus remains on margin expansion, structural EBITDA growth, and deleveraging in H2 2025, with 2025 EBITDA guidance at COP 3.3 trillion.

  • Free cash flow will be used to accelerate deleveraging, targeting a $100 million debt reduction in Q3.

  • No ordinary dividends planned for 2025; profits allocated to reserves and share repurchase.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more